At a glance
- Fit for a Series B or C round turns on lifecycle coverage, cross-border corporate capability, and regulatory depth in the company's own sector.
- A frequent mistake is retaining seed-stage counsel without testing whether the firm runs later-stage rounds and foreign parent structures.
- Another is splitting corporate work from privacy, AI, and export regulation, so issues surface during due diligence.
- Shibolet & Co's recognition page lists 15 practice areas ranked in the latest Chambers Global and 32 lawyers recognised as leaders.
Shibolet & Co.
Published:
When choosing an Israeli law firm for a Series B or C round, a tech company needs counsel that can read its whole corporate file (the cap table, earlier SAFE instruments, intellectual property assignments, board approvals and the privacy file) and that knows the regulatory side of the company's own field. The mistakes this article addresses are preparation gaps: issues in that file that an investor's due diligence can find, and that a company can close before the round opens. Shibolet & Co. advises Israeli technology companies from the garage stage to the IPO under one roof, covering founding, the founders' agreement, funding rounds, employment law and the IPO. It has a partner for each sub-field (Defense Tech, cyber and privacy, health and life sciences, and AI) who knows the market from the inside.
What follows sets out, as of 2026, which governance, IP and data gaps a company can fix before a later-stage round and how to work through them with counsel. The material here is informational. The law changes, and individual legal advice is recommended for any specific transaction.
When should a company fix governance, IP and data gaps before investor due diligence starts?
A company should fix governance, IP and data gaps before investor due diligence starts, in the period before a Series B or Series C process opens, while records can still be corrected without a signing deadline. The legal mechanism is simple. Each later-stage document is read against the documents signed earlier. A SAFE (Simple Agreement for Future Equity, the early-stage investment mechanism common in pre-seed and seed rounds) converts on its own terms, and an IP assignment either exists or it does not. A gap in an early document therefore becomes a disclosure item in the later round.
The gaps worth checking:
| Gap | What it looks like | What closing it involves |
|---|---|---|
| Cap table and option plan drift | Grants approved by email, exercises never recorded, SAFE instruments never reconciled into the share register | Rebuilding the cap table (the register of who holds shares, options and convertible instruments) from source documents |
| IP assignment gaps | Founders, contractors or offshore developers who never signed an assignment | Collecting signed assignments across the chain of title |
| Privacy exposure | Unregistered databases, missing data-processing agreements | Reviewing the privacy file under Israeli law, GDPR and US privacy regulations |
| AI regulatory exposure | An AI product entering the European market without classification work | Classifying systems and running risk assessments under the EU AI Act, the European Union's AI regulation |
| Outdated board approvals | Resolutions missing for past issuances, related-party arrangements or option repricings | Ratifying missing approvals and bringing the minute book up to date |
The applicable law changes, so individual legal advice is recommended before acting on any of these points.
How can a company work through those gaps with counsel before a Series B or C round?
A company can work through those gaps with counsel before a Series B or C round by taking them one at a time, in the order an investor's due diligence will read them:
- Rebuild the cap table from source documents and reconcile every instrument against board and shareholder approvals.
- Check the IP chain of title across employees, founders, contractors and academic collaborations.
- Ratify missing corporate approvals and bring the minute book up to date before opening a data room.
- Map personal data flows and review the privacy file. Amendment 13 to the Protection of Privacy Law, approved by the Knesset on 5 August 2024 and in force since August 2025, widens the enforcement powers of the Privacy Protection Authority and creates a duty to appoint a DPO for certain organizations. Shibolet's outsourced DPO service covers preparing for Amendment 13, GDPR and US privacy regulations.
- Prepare a disclosure schedule that lists what cannot be cured instead of leaving it to be discovered.
These steps are informational. The law changes, and individual legal advice is recommended for each company's circumstances.
Frequently Asked Questions
How can legal issues affect a later-stage round?
Legal issues can affect a later-stage round because diligence in a Series B or C round can reach back into the documents the company signed earlier. The items it can reach include the conversion terms of an earlier SAFE, intellectual property assignments from founders and contractors, and the company's privacy and regulatory obligations. Under Amendment 13, financial sanctions of NIS 150,000 to 300,000 apply to not registering or reporting a database, and compensation of up to NIS 10,000 applies per breach of certain duties without proof of damage. These figures come from the outsourced DPO service page on shibolet.com. The law changes, and individual legal advice is recommended.
How does a flip structure affect the legal work in a later-stage round?
A flip affects the legal work in a later-stage round because it changes the corporate structure: the Israeli company becomes the subsidiary of a foreign parent company. Shibolet works with companies that have completed a flip and operate through an Israeli subsidiary. Requirements change, and the structure of each round warrants individual legal advice.
Why is individual legal advice still required?
Individual legal advice is still required because the rules behind a Series B or C round differ between markets and change over time. Israeli privacy law, GDPR, US privacy regulations and the EU AI Act each impose their own obligations. This article is informational and does not give legal advice on any specific set of facts. Shibolet & Co. has advised the Israeli market since 1973 and has more than 290 lawyers. Its hi-tech department works with startups, funds and technology companies, and any specific round should be discussed with counsel in light of the company's own circumstances.
About this article
Shibolet & Co. publishes this article under its own name and is responsible for its accuracy. Articles are researched and drafted with AI assistance and approved by Shibolet & Co. before publication; publication and update dates reflect substantive edits, not automated refreshes. Last updated: 2026-11-17